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Highlights 
The increasing incidence of tuber-
culosis infection and active disease 
in the United States raises signifi-
cant issues because much of the 
increase has occurred in popula-
tions involved with the criminal 
justice system. Persons with TB, 
moreover, afe often also infected 
with HIV. In addition, new strains 
of drug-resistant TB have appeared 
in part because of patients' failure 
to follow prescribed courses of 
medication. Unless inmates with 
TB infection and disease are identi-
:d and appropriately treated 
while incarcerated, TB-including 
drug-resistant TB---can later de-
velop among released inmates, 
who then may transmit the infec-
tion to their families, community 
corrections officials, and the 
general public. 
Challenges and opportunities fac-
ing the criminal justice community 
concern: 
• Screening inmates, parolees, 
probationers, and criminal justice 
staff for TB infection and active 
disease. 






- Providing training and 
education to staff in under 
standing how the infection is 
transmitted and what can be 
done to contain its spread. 
continued on p.2 
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The resurgence of tuberculosis (TB) in 
the United States, the occunence of sev-
eral major outbreaks of TB in prisons, 
and the concentration in prisons and 
jails of persons at high risk for TB sug-
gest the need for treatment and control 
measures at all phases of the system-
from pretrial release to incarceration to 
parole. The population that comes under 
the supervision of the criminal justice 
system is at relatively high risk for TB. 
This population tends to be poor and 
includes dispropm1ionate numbers of 
racial and ethnic minorities, recent im-
migrants from high-incidence countries, 
injection drug users, and individuals in-
fected with HIV. In general, this popula-
tion is characterized by poor access to 
health care. 
Conectional facilities may be high-risk 
settings for TB transmission because of 
overcrowding, inadequate ventilation, 
and high concentrations of TB infection 
and disease. Inmates released into the 
community pose special problems. They 
may carry TB infection or disease with 
them; and if they interrupt their course 
of treatment, their disease may become 
drug resistant and thus all the more 
dangerous to them, their families, and 
to the community at large. Parole and 
probation officers may also be at risk 
of infection through contact with their 
clients. 
Many prison and jail systems have active 
screening programs for identifying inmates 
with TB infection and disease and for pro-
viding appropriate treatment. What hap-
pens when individuals on TB therapy 
return to the community? The probation 
and parole agencies that supervise them 
could work with public health departments 
to identify clients with TB infection and 
disease and encourage compliance with 
prophylactic and treatment regimens. 
Although such opportunities for TB con-
trol may exist, there are challenges to 
translating them into action. 
This Research in Action presents an over-
view of tuberculosis as a criminal justice 
and public health issue and discusses the 
particular problem ofTB in community 
conections. It reports on six examples 
of TB control efforts in community correc-
tions and summarizes some of the prob-
lems and benefits that can be expected. 
Special attention is given to inmates 
released on parole, but the policies and 
strategies discussed can be tailored 
to other community corrections settings. 
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Highlights 
continued . .. 
- Establishing protective 
procedures for staff. 
- Ensuring prophylactic therapy 
for infected inmates and an 
appropriate medical regimen 
for those with active disease. 
- Linking with public health 
agencies to ensure followup 
with releasees. 
An examination of six community 
corrections jurisdictions indicated 
that the development and implemen-
tation of effective policies and proce-
dures for TB control involve close 
cooperation with State and local 
health departments. 
Challenges to establishing effective 
interagency cooperation include dif-
ferences in perceptions of roles and 
responsibilities between justice and 
public health agencies. However, 
where effective TB control programs 
already exist in community correc-
tions agencies, health departments 
have been key players; they have 
provided training and other educa-
tional materials, screening and treat-
ment services, as well as coordination 
of treatment for inmates released 
while receiving TB treatment or pre-
ventive therapy. 
Detection and transmission 
The resurgence of TB as a public health 
problem is the result of the association of 
TB with the HIV epidemic, immigration 
from countries where TB is common , 
transmission ofTB in congregative set-
tings (e.g., correctional facilities), and 
the de-emphasis and dismantling of a 
national detection and control infrastruc-
ture. Moreover, the increased risk of ex-
posure resulting from rising rates of TB 
infection and disease is exacerbated by 
the presence of HIV infection in the 
same populations. 
Tuberculous infection in persons with 
intact immune systems does not typically 
progress to active disease within the first 
year or two of infection and may never 
do so. An initial infection typically goes 
unnoticed. The infection generally enters 
a latent phase after a few weeks, where 
it may remain dormant or ~ay become 
active at a later time (see "Tuberculosis 
Glossary"). Early signs of active disease 
include fever, chills, fatigue, weight loss, 
and night sweats. 
Susceptibility to TB is thought to in-
crease among persons with damaged or 
suppressed immune systems. It has been 
shown that where co-infection with HIV 
exists, an individual is far more likely 
to develop active and infectious TB dis-
ease. In a New York State prison study, 
for example, HIV -infected prisoners 
were not necessarily more likely to be-
come infected with TB, but they were 
far more likely to develop active disease 
once infected than were HIV -negative 
prisoners.1 
Detection. Infection with TB is generally 
detected through the standard tuberculin 
skin test (also known as a PPD or Man-
toux test). In individuals with compro-
mised immune systems (caused 'by HIV 
infection, another disease like leukemia , 
2 
or a history of chemotherapy or treat-
ment with steroids), a phenomenon 
called anergy often leads to false nega-
tive skin test results. Anergy testing can 
help to distinguish a true negative from a 
false negative skin test result. However, 
the Centers for Disease Control and 
Prevention (CDC) recommend that "all 
HIV -infected persons-whether anergic 
or not-should receive a chest radio-
graph and further diagnostic evaluation 
if indicated."2 
Transmission. TB is not usually a highly 
contagious disease but, given the right 
conditions (such as crowding, poor venti-
lation and increased close contact with 
persons with active disease), the prob-
ability of transmission increases signifi-
cantly. Persons with active pulmonary 
TB can spread the disease through 
coughing, sneezing, laughing, or other 
means that result in the propulsion of 
ai rborne droplets carrying the bac t. ri a. 
Prolong d, close exposure is as. o ·ialed ( 
with increased rates of transmission. It 
is possible to contract TB from contami-
nated articles or dust, but this is very 
rare. Persons with extrapulmonary TB do 
not normally represent a public health 
risk (see "Tuberculosis Glossary"). 
A constellation of factors often exists in 
prisons and jails that makes the trans-
mission of TB more likely than in other 
settings. These factors include crowding, 
old and inadequate ventilation systems, 
and the concentration in close quarters 
of people at elevated risk for TB due to 
substance abuse and poor access to 
health care. Individuals with HIV who 
become infected with TB are far more 
likely to become infectious to others be-
cause of the increased probability that 
their infection will progress to active 
pulmonary disease. Correctional popula-
tions and the communities from which 
inmates generally come may also includ, 
• Research in Action ••• 
,Teater numbers of immigrants from 
countries with high rates of TB. 
A serious outbreak of multidrug resis-
tant TB (MDR-TB) in New York State 
prisons in 1990-91, which claimed the 
lives of 36 inmates and one correc-
tional officer, helped to focus national 
attention on this problem. However, 
this outbreak was not the first indica-
tion that a TB problem existed in 
prison. A survey conducted by the 
Centers for Disease Control and Pre-
vention (CDC) in 1984--85 found that 
in the 29 States studied, the incidence 
of TB disease among inmates was more 
than three times the rate in the total 
population of those same States. CDC 
also noted the occurrence of at least 
ll TB outbreaks in the prisons of 8 
States between 1985 and 1989. In fact, 
studies dating back at least to 1950 
have shown that the incidence of TB 
: s higher in prisons than in the total 
,JOpulation.3 
Prison inmates are often moved from 
facility to facility. This mobility pro-
vides new opportunities to spread 
infection. Almost all inmates return 
to the communities from which they 
came and, if they carry infection with 
them, they can add to increasing rates 
of TB in these communities. 
Treatment 
Periods of incarceration afford oppor-
tunities to implement preventive 
therapy and treatment that can help 
inmates with TB and protect people 
in present and future close contact 
with them. 
The probability that an infection will 
progress to active disease is consider-
ably reduced with preventive therapy. 
Individuals who are infected with 
TB are often prescribed a course of 
preventive therapy, which involves 
taking an anti-tuberculosis medic-
ation for 6 to 12 months, depending 
on HIV status. The drug most fre-
quently used for preventive therapy 
is isoniazid, which can be given daily 
or twice weekly. CDC recommends 
that a medical worker (or a specially 
trained corrections officer) should 
watch the inmate swallow each dose 
Tuberculosis Glossary 
xtrapulmonary TB: Active TB 
where the disease is not localized in the 
lungs, but in other anatomical sites such 
as the kidneys, spine, or intestines. It is 
rarely infectious. Transmission is possible 
in the rare cases of contact with a dis-
charge (such as from an open wound) 
that contains TB bacilli. 
Mantoux (also known as the PPD) 
test: The preferred skin test for detecting 
TB infection. A purified protein derivative 
(ppd) of killed TB bacteria is injected be-
tween the top layers of the skin. Between 
48 and 72 hours later, a health care 
worker determines the presence or ab-
sence of TB infection based on the diam-
eter of the swelling at the injection site. 
Multi-drug Resistant TB (MDR-TB): 
Primary or Reactivat ion TB that is resistant 
to at least two TB medications, most 
commonly isoniazid and rifampin. MDR-
TB occurs primarily in individuals with 
active disease who interrupted, inaccu-
rately followed, or failed to complete 
the initially prescribed medical reg imen, 
Mycobacterium bacilli: The Latin medi-
cal term for the Tuberculosis bacteria. 
Primary TB: The infection progresses 
directly to active disease within a few 
•• 3 •• 
of medication and should monitor the 
patient for adverse reactions; this 
process constitutes directly observed 
preventive therapy.4 
Treatment for TB disease may involve 
a battery of drugs. The actions of the 
three major anti-TB drugs are differ-
ent, but each acts in combination with 
the body's defenses to effect healing. 
Treatment reg~mens are relatively 
long. 
months to a year or 2 after initial infec-
tion. This occurs in about 5 percent of 
newly infected persons, but may be more 
common in individuals with HIV infection 
or other immunosuppressive conditions. 
Pulmonary TB: Active TB where the dis-
ease is localized in the lungs. This form of 
the disease is usually infectious since the 
bacilli move easily into the air through tiny 
droplets exhaled when individuals with 
pulmonary TB cough or sneeze. 
Pulmonary TB should be suspected among 
offenders with heavy coughing, chest 
pain, hoarseness, and spitting blood, 
which are indicative of advanced stages 
of the disease. Offenders with these 
symptoms should receive a chest radio-
graph and bacteriologic examination of 
sputum in order to confirm the diagnosis 
of TB regardless of the skin test result. 
Reactivation TB: TB infection is latent 
for 1 or 2 years, sometimes longer, but 
then progresses to active disease. Overall, 
infected persons have an estimated 5 to 
1 0 percent risk of developing active dis-
ease during their lifetime. For persons 
co-infected with TB and HIV, the risk 
increases dramatically to 1 0 percent 
each year. 
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Individuals with active disease must 
be isolated until they are no longer 
infectious and must generally take two 
or more anti-tuberculosis medications 
for 6 to 12 months, again depending on 
HIV status and drug susceptibility test 
results. Again, CDC recommends di-
rectly observed therapy in treatment 
of active disease.5 
By completing the prescribed course 
of treatment, persons with active infec-
tious disease can achieve a noninfec-
tious state where the progress of the 
disease is arrested. Incomplete or 
inconsistent treatment can result in 
the development of drug resistance. 
This drug-resistant TB (MDR-TB) 
can then spread to other noninfected 
individuals. The emergence of drug 
resistance has posed serious problems 
for TB control. In some cases of MDR-
TB, effective drug regimens have not 
been identified. 
Control 
Public health measures can help to 
interrupt the cycle of disease transmis-
sion and safeguard those who work and 
live with inmates or former inmates. 
While in prison, inmates may be 
encouraged to be more compliant 
with treatment regimens. Monitoring 
mechanisms, such as directly observed 
therapy and directly observed preven-
tative therapy, are easier to implement 
because of the greater control main-
tained over inmates than over citizens 
in the outside community. Indeed, 
CDC found that nearly 30 percent 
more correctional inmates than drug 
treatment clients completed their TB 
therapy.6 
Infection control measures should be 
introduced whenever there is a risk of 
disease transmission. Facility infection 
control measures include the improve-
ment of ventilation and the use of air 
filters and ultra-violet light. Individual 
control measures include: 
• Isolating persons with known or 
suspected active TB. 
• Monitoring TB infection status 
through the tuberculosis skin test to 
permit action to be taken where there 
is evidence of new infection. 
e Ensuring that those who are 
infected or have TB comply with 
treatment regimens. 
e Limiting close contacts with 
persons who have active TB. 
• Asking all people to cover their 
mouths when coughing and dispose 
of soiled tissues in a careful manner. 
These activities can continue into the 
community corrections system once 
the prisoner is released. Even though 
the offender is no longer incarcerated, 
he or she is still under the jurisdiction 
of the criminal justice system, is re-
porting regularly to a parole officer, 
and may be living in housing arranged 
by this system. 
The correctional system's contacts 
with community corrections organiza-
tions can be used either to establish or 
encourage the releasee's continued in-
volvement with a public-health-based 
Tuberculosis in the United States 
uberculosis is a mycobacterial dis-
ease with a worldwide distribution. In the 
United States prior to 1985, the incidence 
of TB had been declining steadily for sev-
eral decades, with an average annual de-
cline of about 5.8 percent. Between 1985 
and 1992, however, the number of TB 
cases increased by 20 percent. 
Who contracted TB in the United 
States during this period of resurgence? 
Research has shown that: 
• Two-thirds of the "excess" cases-that 
is, the cases in excess of the numbers that 
would have been expected had the pre-
1985 downward trend continued-were 
among males, and 90 percent of these 
cases were among individuals 25 to 44 
years of age. 7 
• Increases in TB were also found to be 
heavily concentrated among racial and 
ethnic minorities, with case rates per 
•• 4 • 
1 00,000 ranging from 4.0 per 1 00,000 
in non-Hispanic whites to 46.6 in Asians 
and Pacific Islanders. 
• Immigrants accounted for 60 percent 
of the total increase in the number of TB 
cases in the United States. 
• Five States accounted for 92 percent 
of the total U.S. increase: California, 
Florida, New Jersey, New York, and 
Texas. The number of TB cases grew fast-
est in States with high cumulative rates 
of HIV/AIDS, which is not surprising given 
the established relationship between HIV 
and TB.8 
• There was also a definite trend in 
the average annual incidence of TB ac-
cording to socioeconomic status. Esti-
mates ranged from 4.2 per 100,000 in 
the group with the highest median 
household income, to 33 per 1 00,000 
in the group with the lowest-9 
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'B program. Integrating an awareness 
of the releasee's TB status into the 
community corrections process can 
also help staff protect themselves from 
TB infection and disease. Universal 
precautions represent the best ap-
proach to infection control. Even when 
TB is not thought to be present, clients 
and staff should be discouraged from 
coughing or sneezing without covering 
their mouths. However, staff should 
also be notified when releasees they 
are working closely with have active 
TB, so they can take additional pre-
cautions such as undergoing more fre-
quent TB skin tests. Moreover, efforts 
to ensure that releasees have access to 
treatment and are compliant with 
medication regimens will be beneficial 
both for them and the community. 
Exhibit 1. TB Control Strategies in Six States 
States Testing Discharge/Compliance Education 
New York Screemng for Parole officers receive medical data 
both parolees on parolees. 
and staff. Parolees receive referrals to medical Given to parolees, their heads of house-
Frequency providers. hold, and staff. 
depends on Incentives for compliance with 
TB status. treatment. 
Arkansas Medication and counseling on release 
For inmates and provided by county health depart- TB education for at hiring for em- ments. 
PPD-positive inmates. ployees. Failure to seek treatment is a parole 
violation. 
Georgia 
5 taff are tested. Policy under development. 
Currently no educa-




screening for Failure to comply with treatment is a Staff training and dis-parolees in parole violation. tribution of materials. residential 
placements. 
Minnesota Inmates with infectious TB are placed Correctional officers 
Mandatory in isolation in hospitals instead of and inmates receive 
annual screening being released to community. training on blood-
of ·correctional borne pa th~ens and 
inrnales. County health departments are TB. No TB e ucation 
responsible for ensuring compliance. for parolees. 
Texas 
M<.mdatory test- TB training program 
ir1g of correc- Employees with positive tests must for mana!ilerial staff 
tional inmates show physicans' proof that they do of institutional and 
and staff, but not have active TB. community correc-
not parolees. tions agencies. 
~ii? • • 5 • ~~; 
Current practices in six 
jurisdictions 
Several jurisdictions have imple-
mented procedures designed to intro-
duce collaboration between public 
health and community corrections 
agencies, in an effort to help control 
the spread of TB. Their experiences 
are discussed below and summarized 
in exhibit l. 
Interagency Cooperation 
Intensive Releasee Assistance Program for clients 
with HIV and TB. 
Matching program with health department to 
identify parolees noncompliant with TB regimen . 
Housind program for parolees co-infected with 
HIV an TB. 
Cooperation between criminal justice and 
health authorities. 
Interagency task force is defining policy on HIV, 
TB, and Hepatitis B. 
Networking among agencies, including the 
Departments of Corrections and Probation 
and Pa role. 
Cr iminal justice and health agencies col laborated 
en 1993 TB screening statu te and are work ing 
together on policy for providing TB medications. 
Close cooperat ion between criminal justice and 
health authorities in drafting and implementing 
TB laws, 
I 
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New York State 
The incidence of TB disease is much 
higher in New York (and in the other 
heavily urban States of the Northeast 
and Middle Atlantic regions) than in 
other parts of the country. Control 
measures appropriate and necessary 
in New York may not be as necessary 
outside large urban areas. 
The New York State Division of Parole 
has developed a series of TB policies. 
Approximately 180 persons with active 
(and potentially infectious) TB are re-
leased from State correctional facilities 
into the New York City community 
each year. 10 
TB screening policies. New York has 
separate guidelines for inmates who 
are infected with TB, those who have 
active disease but are not infectious, 
and those who have active disease 
and are infectious. TB screening is 
required for both parolees and staff. 
TB status is determined on admission 
to a program (including drug and alco-
hol treatment programs), and followup 
testing is conducted for clients who 
have had negative tests. All staff re-
ceive preemployment screening for 
TB, but those at the highest risk of 
exposure are tested every 6 months. 
Testing is performed by the Employee 
Health Service at the worksite and by 
local health care organizations. These 
policies are intended to protect the 
health and welfare of both staff and 
parolees. 
Because of this staff safety emphasis, 
the Division of Parole has considered 
it natural and necessary to involve 
the officers' union in the development 
of TB policy and training. A TB train-
ing curriculum was designed by a 
joint task force of labor and manage-
ment. The Division of Parole has 
also brought in a regular medical 
consultant for the first time. All of 
these initiatives have resulted in good 
cooperative working relations between 
management and labor on TB issues. 
Despite relatively high annual rates 
of skin test conversions among parole 
staff (5.6 percent per year statewide, 
but as high as 23 percent per year in 
some New York City sites), staff alarm 
regarding TB has been effectively 
defused. 
Discharge planning policies andr 
procedures. Discharge planning for 
inmates with TB is a critical starting 
point for an effective community cor-
rections TB policy. Through a collabo-
rative effort between leaders and line 
staff of the New York State Depart-
ment of Correctional Services (DOCS), 
the State Division of Parole, and the 
Health Department, some effective 
discharge planning and followup pro-
cedures for inmates with infectious 
TB have been developed. Unfortu-
nately, because of resource limitations, 
the same level of service is not given 
to persons on TB preventive therapy. 
The facility parole officer includes in-
formation on TB status and the treat-
ment regimen on the medical summary 
for each releasee with TB infection or 
active disease. Compliance history 
and plans for medical followup are 
checked. Consent forms for releasing 
medical information are obtained from 
the inmates. If consent is given, the 
discharge summary is sent to the 
Health Department in the county to 
which the individual is being released. 
However, even if consent is refused, 
State law requires notification of the 
Health Department of all cases of 
active TB. The medical summary is 
sent to the field parole officer. Before 
the prisoner is released, he or she is 
given instruction on the importance 
I 6 I 
of complying with TB treatment or 
prophylaxis as well as a referral to 
a public-health-based TB program. 
Releasees also receive a supply of 
their medications. 
All persons with active TB who are 
about to be released are given an 
appointment with the Health Depart-
ment or a private care provider in the 
community in which they will live. 
The referral and appointment sheet 
includes the names and telephone 
numbers of three individuals (who ac-
tually have knowledge of the case): a 
DOCS health services staff member, a 
Division of Parole staff member, and 
a Health Department staff member or 
private health care provider. 
Each New York City releasee with 
active TB also receives an incentive 
to follow through on treatment-a $25 
voucher good for transit tokens or food 
coupons. One-half of the value is re-
deemable upon keeping the first treat-
ment appointment and the other half 
on completion of 1 week's directly 
observed therapy. Outreach workers 
employed by the New York City De-
partment of Health assist in locating 
patients and inducing them to remain 
on their medication. 
Compliance in the community. As 
a result of these and other strategies, 
overall compliance with medication 
regimens among persons with active 
TB released from New York City cor-
rection facilities has increased from 
about 10 percent to about 70 percent 
in a single year. 
Inmates determined to be infectious 
are released to health care facilities 
for isolation and treatment until they 
are no longer infectious. Such parolees 
are permitted to make arrival reports 
to their parole officers by telephone 
Research in Action ••• 
·ather than in person. The parole of-
ficer then contacts the health care fa-
cility to arrange to be informed when 
the parolee is no longer infectious. 
Once the individual is released to the 
community, his or her field parole of-
ficer reviews the medical summary 
and discusses treatment status with 
the parolee. The officer also provides 
additional referrals as needed and en-
sures that the file contains a consent 
to release medical information. Even 
where no consent is obtained, the field 
parole officer is expected to contact 
the county or city health department 
to provide information that can facili-
tate followup with the releasee. 
If a parolee is discovered after release 
to be infectious or to have been infec-
tious while incarcerated, the parole 
division is responsible for identifying 
and advising staff who may have had 
lignificant contact with the individual. 
Specific recommendations are made 
for different situations. 
The Releasee Assistance Program 
(RAP) is a specialized program of the 
New York Division of Parole for cli-
ents with HIV disease and TB. RAP 
serves only New York City, where 
most of these patients live, and pro-
vides intensive case management, 
crisis intervention, medical advocacy, 
and other supportive services. RAP 
parole officers, who have much smaller 
than normal caseloads, have provided 
critical assistance to many parolees 
in the areas of medical care, housing, 
entitlements, substance abuse treat-
ment, and reestablishment of relations 
with their families. RAP parole 
officers do not provide directly ob-
served therapy for parolees on TB 
medications. However, the program 
·.vorks with parolees to adhere to their 
regimens and offers incentives for 
adherence, such as vouchers for 
subway tokens and food coupons. 
TB education programs. Education 
about TB is available for parolees in 
New York State, as well as for families 
of parolees and for parole staff. The di-
vision issues an information kit called 
"A Healthy New Start" to all persons 
being released on parole. The kit is 
also sent to the head of the household 
to whom the inmate will be released. 
The Division of Parole also has a tu-
berculosis training program for staff, 
including information on symptoms, 
infection control measures, treatment, 
the connection between HIV and TB, 
the problem ofMDR-TB, contact in-
vestigation, case reporting, and Divi-
sion of Parole procedures for contact 
between staff and releasees. 
Cooperation with health department. 
There has been active cooperation 
and information sharing on TB cases 
between the State Department of 
Health and the Division of Parole. 
The New York State Department of 
Health assisted the Division of Parole 
with information and advice on devel-
opment of policies, guidelines, and 
education programs and materials. 
In the spring of 1994, the Bureau of 
Tuberculosis Control of the New York 
City Department of Health and the 
State Division of Parole agreed to 
conduct a pilot data matching pro-
gram, in which the Division of Parole 
assisted in the location and return to 
treatment of parolees with TB who 
were non-compliant with medication 
regimens. This was done by matching 
the list of "unable to locate" cases pro-
vided by the Health Department with 
the data base of parolees maintained 
by the Division of Parole. Health De-
partment personnel, in turn, informed 
• 7 •• 
the appropriate parole officer of 
control measures or precautions that 
should be used in further contacts 
with the parolee. This pilot program 
identified only 6 complete matches 
out of 100 names; 1 of these individu-
als was subsequently located. The 
number of matches achieved in this 
pilot test was lower than expected. 
Another match of 100 names from 
the Health Department's "unable to 
locate" list and the parolee data base 
was attempted during 1994, and no 
matches were found. Health Depart-
ment staff suspect that this result 
may have been an outcome of better 
followup with State prison parolees 
so that they rarely appeared on the 
"unable to locate" list. In any case, 
another match attempt will probably 
be made during 1995. 
Although the New York experience 
has not yielded many matches, the 
approach remains a promising strategy 
for jurisdictions seeking to improve 
TB followup with parolees and others 
released from correctional facilities. 
This matching program illustrates im-
portant differences in the perceived 
roles of agencies that are attempting 
to forge cooperative relationships to 
combat TB. Under the program, the 
Parole Division helps locate parolees 
who are noncompliant with TB treat-
ment, but the Health Department does 
not reciprocate by helping the Parole 
Division locate persons who are violat-
ing their conditions of parole. This is 
because the success of the Health De-
partment, as a health agency rather 
than a justice system agency, depends 
on b_uilding trust with clients; disclos-
ing information to criminal justice or 
immigration authorities would quickly 
undermine this trust. 
•• Research in Action •• 
The most recent example of inter-
agency cooperation with respect to TB 
in New York is in the development of 
a community-placement pilot program 
for housing individuals co-infected 
with HIV and TB. The Department of 
Conectional Services, the Division of 
Parole, and the AIDS Institute of the 
Health Department are working to-
gether to identify two or three sites for 
this purpose. The facilities will be 
open to the community at large, and 
thus other agencies could place pa-
tients there as well. The Division of 
Parole will be able to place its clients 
in these residential facilities but will 
not be guaranteed a fixed number of 
beds in them. 
Arkansas 
The TB control program in the Arkan-
sas Department of Corrections (ADC) 
is funded through a grant from the 
Centers for Disease Control and Pre-
vention. A central TB Control Program 
Director oversees both the Health 
Department and ADC, and an ADC 
employee directs TB control activities 
for inmates and those about to be 
released. 
Prisoners being released who are re-
ceiving medication for TB treatment 
or prophylaxis leave the facility with 
a supply of medication, and a notifica-
tion letter is sent to the health depart-
ment in the county where they will 
live. Medication and counseling 
are provided by the county health 
departments free of charge to the pa-
rolees. Parolees in Arkansas who are 
on TB medication must, as a condition 
of their parole, report to their county 
health department within 7 days of 
their release. If a releasee does nor 
show up for treatment, the health de-
partment notifies the parole officer, 
as failure to seek treatment constitutes 
a parole violation in Arkansas. 
The county health departments super-
vise TB treatment and medication 
compliance. Parole officers become 
involved if parolees fail to show up 
for treatment but are not otherwise 
charged with responsibilities for test-
ing, refenal, and the monitoring of 
compliance in Arkansas. The county 
health departments monitor treatment 
compliance for parolees more closely 
than for other patients, but directly 
observed therapy is not the norm. 
Arkansas community corrections staff 
are tested for TB infection when they 
are hired. In late 1994, State officials 
implemented a mandatory TB screen-
ing program for conections staff, paid 
for by ADC and performed by the 
county health departments. 
Georgia 
An interagency task force involving 
representatives from the State criminal 
justice system and the State health 
department is drafting a policy for in-
fectious disease control in community 
conections that will cover HIV, TB, 
and Hepatitis B. Agencywide staff 
testing for tuberculosis infection 
was undertaken in the State's parole 
agency in 1992. This was intended to 
serve as a baseline. Staff screening 
was canied out again in the fall of 
1994, and the agency is working to-
ward a policy of annual testing. Test-
ing is done through the conectional 
system's health services facilities, 
except when a parole officer is too far 
from such a facility. In these cases, 
testing is done at a nearby county 
health department. As yet, however, 
there is no screening of parolees in 
Georgia. 
South Carolina 
The Department of Probation and Pa-
role is not routinely notified of the TB 
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status of parolees. Rather, the Depart- · 
ment of Conections notifies the appro-
priate county health department when 
parolees with TB are released to that 
jurisdiction. 
Parolees in residential placements (for 
example, restitution centers, half-way 
houses) receive mandatory annual 
screening for TB infection. Parolees 
living at home are not required to un-
dergo annual testing, however. Parole 
officers are required to send parolees 
with suspected active TB for followup. 
Failure to comply with treatment for 
active TB may be a parole violation in 
South Carolina if the offender has been 
notified of his or her obligations in 
this regard. During the last year there 
has been increased interagency net-
working in South Carolina intended 
to enhance TB control in community 
corrections. There have also been in-
creases in inservice staff training and 
distribution of informational materials 
on TB to community corrections staff. 
Minnesota 
In Minnesota, a State statute provides 
for TB screening of inmates and em-
ployees of facilities operated, licensed, 
or inspected by the Department of Cor-
rections. However, it does not cover 
parole officers, who are not viewed as 
being at risk in Minnesota. Neither 
officers nor parolees receive annual 
screening for TB. 
Under no circumstances are inmates 
with infectious TB released to live in 
the community in Minnesota. Instead, 
they are placed in isolation in hospi-
tals. Inmates who need TB preventive 
therapy are referred to a county health 
department. It is not a responsibility 
of the parole officer in Minnesota to 
determine whether or not a parolee is 
compliant with treatment regimens. 
Research in Action • 
rexas 
Texas law requires TB screening of in-
mates, staff, and volunteers in county 
jails, prisons, and other community 
corrections settings. Parolees living in 
the community are not required to be 
screened for TB, however. Employees 
and volunteers must be tested for TB 
infection, and if they test positive, 
must show proof from their own physi-
cians that they do not have active TB. 
The employee must pay the expense of 
the screening test and any followup or 
treatment. Inmates must be tested if 
they are to be confined in any facility 
for more than 14 days. The Texas De-
partment of Health supplies the mate-
rials for testing and treatment, and the 
Texas Department of Criminal Justice 
provides funds for administering the 
screening, further testing, and treat-
ment for offenders suspected of having 
active TB disease. Counties share in 
his funding for certain classes of in-
mates. TB cases must be reported to 
the appropriate health authority within 
3 days. 
The Texas Department of Criminal 
Justice and the Department of Health 
worked closely together to draft the 
law relating to TB screening and treat-
ment for staff and inmates of county 
jails and other correctional facilities . 
The implementation of the law also 
necessitated close cooperation. 
A TB training program is offered peri-
odically by health departments at the 
judicial district level in Texas. So far, 
this training has been provided to 
management staff of institutional 
and community corrections agencies 
but not to inmates or parolees. 
Implications 
~ole definitions. Disease control is 
outside the normal scope of perceived 
How Health Departments and Community Corrections 
Agencies Can Work Together 
espite the complexities involved in 
working out TB control programs, the 
benefits for the community, for commu-
nity corrections staff, and for clients are 
clear. Departments of public health, 
charged with protecting the public from 
the spread of disease, and faced with ad-
dressing this mission in a population that 
may be particularly at risk for developing 
TB, often have no systematic knowledge 
about populations involved with the crimi-
nal justice system or awareness of how to 
use the information that does exist to en-
sure uninterrupted compliance with TB 
therapy. Progress toward achieving high 
rates of treatment completion can be 
greatly enhanced through collaboration 
with community corrections agencies. 
Community corrections staff, charged 
with overseeing the reintegration of of-
fenders into the community, can better 
protect themselves, their clients, and their 
communities by knowing about TB, par-
ticipating in an active screening program, 
being aware of the TB status of their cli-
ents, knowing whether their clients are 
compliant with treatment, and encourag-
ing their compliance. 
Health departments can provide: 
• Assistance in developing and evaluat-
ing polices and procedures (including 
systems for maintaining records) for TB 
control. 
responsibility and operation for most 
community corrections agencies. 
Like other criminal justice agencies, 
probation and parole departments 
see their primary purpose as law en-
forcement. The addition of a such a 
role in coordinating and monitoring 
TB treatment and compliance with 
medication regimens may also be seen 
to increase the workload of already 
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• Training of correctional facilites staff 
responsible for implementing TB control 
program. 
• Information about TB to educate staff 
and the offender population . 
• Coordination of services for screening, 
treatment. and prophylaxis for clients and 
staff of community corrections agencies. 
• Investigation of contacts that TB 
patient has had within the correctional 
system and in the community. 
Community corrections, in turn, can help 
health departments by: 
• Referring clients with TB symptoms to 
TB programs. 
• Helping to ensure TB treatment 
compliance. 
• Helping locate noncompliant clients 
by offering to cross-match lists of 
parolees with health department lists of 
noncompliant individuals (as in New York 
City's pilot program). 
As health departments and correctional 
systems establish linkages and begin to 
work together, other areas of potential 
collaboration may evolve, such as in HIV 
or other infectious diseases. 
overburdened and understaffed 
community corrections agencies. 
However, it is in the best interests of 
staff who must work closely with of-
fenders to be aware of TB cases and to 
be able to work toward protecting their 
own health as well as the health of 
their clients and of the public. The 
most important reason for establishing 
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a new TB control role for community 
corrections staff may be to ensure their 
own and their families' health. 
Lack of knowledge. Clarification of 
roles is not the only challenge. Lack of 
information and knowledge is another 
significant barrier to the effective in-
volvement of community corrections 
staff in TB control. Parole and proba-
tion officers may know very little about 
TB or its means of transmission. They 
may not have information about re-
sources to which they can refer their 
clients for care and treatment. Indeed, 
they may not be aware of available 
anti-TB medications. Further, com-
munity corrections staff may not be 
aware of the importance of treatment 
compliance, or of any of the other di-
mensions of TB control on which they 
may be able to have some impact in 
their day-to-day work with their cli-
ents. Education and training programs 
are needed to address these gaps in 
knowledge. 
Particular problems of probation. 
There can be little discharge planning 
with regard to probationers except for 
those who spend pretrial time in jail. 
Universal TB screening of probation-
ers and followup diagnostic workups 
on suspect cases of TB disease would 
provide information as to the medical 
needs of clients, but such a policy 
would be costly to implement. Given 
these obstacles, probation agencies 
are likely to receive little if any infor-
mation on the medical needs of their 
clients. 
Interagency cooperation. Interagency 
communication and information 
sharing are extremely important in 
effective discharge planning and com-
munity followup. However, medical 
records and information on TB status 
often do not accompany prisoners as 
they leave their institutions. Proba-
tioners and parolees living on their 
own in the community may see no 
reason to divulge information 
concerning their TB status. Health-
related information is generally con-
sidered confidential, and working out 
a system involving medical release 
forms and practices that protect 
the privacy of clients may pose an ad-
ditional difficulty for community cor-
rections agencies. As correctional 
programs and health departments be-
gin to work together, the whole area 
of confidentiality must be carefully 
considered. 
Close inter- and intra-agency collabo-
ration is needed for the integration of 
TB control into the accepted mission 
of community corrections. This takes 
time, effort, and commitment from 
all participants. The fact that public 
health and criminal justice agencies 
may have very different perceptions 
of their roles and responsibilities may 
pose difficulties as potential collabora-
tions are explored. In the States where 
TB control programs in community 
corrections already exist, the health 
department has usually played a key 
role in offering training and develop-
ing materials for use in inservice edu-
cation, as well as providing screening 
and treatment services for clients and 
staff. 
The role of community corrections 
staff in TB control must be defined. 
This can be difficult, as a number of 
possibilities exist, each of which may 
have its own supporters within an 
agency. Community corrections staff 
may assist health departments by 
trying to locate clients who are non-
compliant with treatment. They may 
also be given a significant role in en-
forcing treatment compliance if non-
compliance is specified as a parole 
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violation. Providing refe~;rals for care 1 
may constitute another level of in-
volvement for community corrections 
staff. Offering incentives for seeking 
and complying with treatment may 
also be considered for inclusion in a 
TB control effort. Such incentives may 
include additional services provided in 
a caring manner, as well as vouchers 
for transportation or food. Approaches 
combining incentives and threatened 
sanctions may work best. It is a deli-
cate balance, a key to which is win-
ning the confidence of clients that both 
the incentives and the sanctions will 
be forthcoming as appropriate. 
Community corrections agencies 
have services to offer health depart-
ments in an attempt to achieve better 
TB control (see "How Health Depart-
ments and Community Corrections 
Can Work Together"). To the extent 
that they use these servic l'i, 1 bey ·an 
1 
reduce the probability of infection 
among their own staff and reduce the 
spread of disease in the surrounding 
community. In the case of repeat 
offenders, they can also minimize the 
reintroduction of TB into correctional 
populations. 
The potential impact that these agen-
cies can have is of course shaped by 
the dimensions of the TB problem in 
their own jurisdictions. Even where 
the prevalence ofTB is low, however, 
an isolated case of TB in prison can 
lead to an outbreak; and if controls 
like screening are in place, at least 
some level of protection is available. 
Where the prevalence of TB is high, 
such as in New York City and other 
major metropolitan centers, and known 
cases of active TB reenter the commu-
nity each year, the involvement of 
community corrections programs is 
even more critical in controlling the 
spread of the disease. 
•• Research in Action • 
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